Organization
Andrew J Long, PharmD
1 clinical trial
Clinical trial
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab and Milk Oral Immunotherapy for the Treatment of Patients With Cow's Milk AllergyStatus: Recruiting, Estimated PCD: 2026-10-01